Pennsylvania lost 2,900 pharma jobs in the last five years, but there was a net gain because some pharma executives and scientists went to start-ups.
If you were at risk for developing depression, would you take a pill to prevent it?
For 23 runners at the Rock 'n' Roll Half Marathon, Sunday was about keeping a long streak alive - even at age 87.
They were partners for 34 years. But at the end, it was hard to remember the good times.
They're part of a national effort to reduce kidney stones, which are becoming more common in adults and children.
Jefferson's acquisition of Kennedy is its fourth since Stephen Klasko became CEO in 2013.
GlaxoSmithKline's shingles vaccine gets a vote of support for safety and effectiveness from a Food and Drug Administration panel.
PPD, or paraphenylenediamine, is the world's most popular oxidative hair dye agent - even though it's a nasty allergen with a checkered history going back 150 years.
The Philadelphia-based American Association for Cancer Research's annual report on progress against the disease says immunotherapy and precision medicine continue to drive the field forward.
Orthopedic surgeons should avoid sponsorship deals with teams and not participate on the sidelines at games, say the authors of an editorial in a Philly-based medical journal.
After a months-long search, it selected Kare Schultz, an industry veteran who comes from Denmark's H. Lundbeck A/S.
Penn Memory Center and Children's Hospital of Philadelphia give cognitively impaired patients a way to give back.
More than $160,000 was raised for Philadelphia's Ronald McDonald House.
GlaxoSmithKline and Adaptimmune Therapeutics sealed a deal for GSK to develop and commercialize a promising T-cell therapy to treat cancer.